Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
44M
-
Shares change
-
+5.28M
-
Total reported value, excl. options
-
$1B
-
Value change
-
+$119M
-
Put/Call ratio
-
1.99
-
Number of buys
-
73
-
Number of sells
-
-74
-
Price
-
$22.74
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q3 2019
214 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q3 2019.
Editas Medicine, Inc. - Common Stock (EDIT) has 175 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44M shares
of 82.8M outstanding shares and own 53.17% of the company stock.
Largest 10 shareholders include Sumitomo Mitsui Trust Holdings, Inc. (4.96M shares), Nikko Asset Management Americas, Inc. (4.96M shares), ARK Investment Management LLC (4.93M shares), VANGUARD GROUP INC (4.32M shares), BlackRock Inc. (4.12M shares), STATE STREET CORP (2.19M shares), Capital World Investors (1.76M shares), FEDERATED INVESTORS INC /PA/ (1.44M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.16M shares), and MORGAN STANLEY (1.05M shares).
This table shows the top 175 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.